HCV replication inhibitors (Southeast University/University of Minnesota/Suzhou Nanomicro Technology Company)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameHCV replication inhibitors (Southeast University/University of Minnesota/Suzhou Nanomicro Technology Company)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHepatitis C virus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesSoutheast University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSuzhou Nanomicrotech Research Institute Co LtdUniversity Of MinnesotaSoutheast University
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A